Navigation Links
Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
Date:6/25/2009

Company Also Receives Patent Covering ARIKACE for Once-Daily Treatment of Pseudomonas Lung Infections

MONMOUTH JUNCTION, N.J., June 25 /PRNewswire/ -- Cystic Fibrosis Foundation Therapeutics Inc., the nonprofit affiliate of the Cystic Fibrosis Foundation, has provided a $2.2 million award to Transave Inc., for the continued development of ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that aims to treat Pseudomonas lung infections in cystic fibrosis (CF) and non-CF bronchiectasis patients. Transave announced today that the award will be used to support an ongoing Phase II clinical trial in U.S. CF patients with Pseudomonas lung infections and a preclinical study. The company also reported today completion of enrollment for its second CF Phase II clinical trial; results are expected to be available in July. The first CF Phase II trial, completed in June 2008, achieved positive results.

In other developments, the company announced that it was granted a patent for ARIKACE by the U.S. Patent and Trademark Office. U.S. Patent No. 7,544,369 entitled "Sustained Release of Antiinfectives" covers ARIKACE for the once-daily treatment of Pseudomonas lung infections.

"We have followed and supported Transave's work in this area from the beginning, and we are excited to play a role in potentially bringing another new treatment option to CF patients," said Robert J. Beall, Ph.D., President and CEO of the Cystic Fibrosis Foundation. "The potential for ARIKACE is encouraging, both in terms of possible lung function improvements and quality of life outcomes."

Under the terms of the agreement, Transave stands to receive $2.2 million upon achievement of certain milestones. Cystic Fibrosis Foundation Therapeutics provided a previous award of $1.7 million to support the development of ARIKACE.

"We believe ARIKACE -- a once-a-day treatment with sustained
'/>"/>

SOURCE Transave, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the nation,s ... Polaris Medical Imaging, a leader in sales, service and ... acquisition allows BC Technical to continue to expand their ... MR and CT modalities. "We are ... Mark Alvarez , president and CEO of BC ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... WESTON, Fla. , June 15 DHL Global Mail ... of mail-order pharmacies. DHL SMARTMAIL PHARMA SELECT ™ incorporates best ... the pharmaceutical industry. Thanks to this expertise and Global Mail,s nationwide ... accountability and value. , , ...
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President ... Goldman Sachs Global Healthcare Conference on Tuesday, June 15 , at ... in Los Angeles .  The presentation will be webcast on the ... , , ...
Cached Medicine Technology:DHL Global Mail Launches Specialized Shipping Service for Mail-Order Pharmacies 2
(Date:8/31/2014)... August 31, 2014 This September, ... California State Library, celebrates 30 years of changing ... Since its inception, California’s Library Literacy Services has ... learn to read and write. , To mark ... the state is launching a month-long awareness campaign ...
(Date:8/31/2014)... Sunday 31 August 2014: Renal denervation seems to ... with resistant hypertension when it includes accessory renal arteries, ... Dr Linda Schmiedel from Germany. , Dr Schmiedel said: ... hypertension, which is defined as blood pressure (BP) greater ... from resistant hypertension (rHTN) and are unable to reduce ...
(Date:8/30/2014)... August 2014: A new method to predict the ... was presented at ESC Congress today by Dr Benjamin ... needs 350 AEDs located in public places for optimal ... Dr Dahan said: "Out of hospital cardiac arrest is ... ranging between 50 and 100 per 100 000 in ...
(Date:8/30/2014)... Walking-Canes.Net has released several articles related ... can help in making gait problems easier. The new ... website that contains all of the news articles that were ... articles deal with diseases that make walking a problem and ... help in making life easier for the patient. The articles ...
(Date:8/30/2014)... Cokato, MN (PRWEB) August 31, 2014 ... renewed in home renovation, especially spa style bathrooms and ... (NASS) has observed an increase in interest not ... understanding the history, culture and health benefits of sauna. ... Finnleo , the North American Sauna Society provides ...
Breaking Medicine News(10 mins):Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Renal denervation more successful when it includes accessory arteries 2Health News:New method predicts optimal number and location of AEDs 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2Health News:As Interest in Saunas Increases, the North American Sauna Society Increases Outreach to Provide Education on History, Design, and Culture 2
... compared to kids without disorder , MONDAY, Oct. 19 ... in blood mercury levels between children who are developing ... disorders. , The findings, appearing online Oct. 19 in ... some of the debate surrounding mercury and autism. , ...
... not trained in skin cancer examinations, nor have they ever ... the October issue of Archives of Dermatology , one ... that can be detected early for which U.S. death rates ... Although melanoma remains the second most common cause of cancer ...
... WASHINGTON, D.C., October 19, 2009 With chronic diseases ... solutions to improve care and outcomes for these often ... today announced a new initiative funded with a grant ... will allow pediatricians across the country to pilot a ...
... a joint letter to the Centers for Medicare and ... fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a ... only one FDG-PET study during initial treatmenta limitation that ... under certain circumstances. "It is absolutely critical for ...
... ... Assara Laser Cosmetic Services Centers and Park Avenue Laser Vision ... dedication to providing exemplary care in the cutting-edge laser cosmetics field. ... laser spider vein removal and laser facials. Park Avenue Laser Vision ...
... ... Access, Choice, and Flexibility. , ... Albany, NY (Vocus) October 19, 2009 -- In a continuous effort to develop products and ... benefits, CDPHP ® announces several enhancements to take effect in 2010 pending New York ...
Cached Medicine News:Health News:Mercury Levels Not Abnormal in Autistic Children 2Health News:Mercury Levels Not Abnormal in Autistic Children 3Health News:Resident physicians seldom trained in skin cancer examination 2Health News:Pediatricians put proven treatment strategies to work against childhood asthma 2Health News:1 scan per patient is not always enough 2Health News:Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 2Health News:Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 3Health News:CDPHP Launches National Network and Three-In-One Plan, and Expands Member Incentives 2Health News:CDPHP Launches National Network and Three-In-One Plan, and Expands Member Incentives 3Health News:CDPHP Launches National Network and Three-In-One Plan, and Expands Member Incentives 4
Comfor™ Cast Boot - Rocker Sole - Closed Toe...
The Multi-Purpose Medical-Surgical Shoe...
... assay for the qualitative and ... to Gliadin in human serum. ... be used as an aid ... disorders, mainly Coeliac Disease. This ...
... For use as a non-reactive quality assurance reagent ... Toxoplasma gondii (TOXO IgG and TOXO IgM), IgG ... and rubella IgM), IgG and IgM antibodies to ... IgM antibodies to herpes simplex virus types 1 ...
Medicine Products: